More than 5,000 potentially life-changing treatments for rare diseases are currently languishing on pharmaceutical company shelves, representing a vast reservoir…
Read More
Eli Lilly and Ascidian Therapeutics Forge Strategic Alliance to Revolutionize Kidney Disease Treatment Through Advanced Genetic Medicine
Eli Lilly and Company has announced a significant research collaboration and licensing agreement with Ascidian Therapeutics, a pioneering biotechnology firm…
Read More
Scientists Develop High Potency Vitamin K Analogues to Drive Brain Cell Regeneration in Neurodegenerative Disease Research
The global medical community is currently witnessing a paradigm shift in the approach to treating neurodegenerative conditions such as Alzheimer’s,…
Read More
Pioneering New Tool Maps Brain’s Waste Disposal Routes, Revealing Crucial Insights into Neurological Health and Disease
Scientists at the Gladstone Institutes in California, USA, have achieved a significant breakthrough, developing an innovative tool that allows for…
Read More
Singaporean Scientists Unveil Revolutionary Spinach-Derived Photosynthetic Treatment for Chronic Dry Eye Disease
The landscape of ophthalmological treatments is on the cusp of a profound transformation, spearheaded by groundbreaking research from the National…
Read More
Indiana University School of Medicine Researchers Revolutionize Bone Marrow Imaging with Breakthrough Multiplex Technique to Advance Disease Treatment
The Indiana University School of Medicine has announced a significant leap forward in regenerative medicine and oncology through the development…
Read More
Molecular Switch in Brain Immune Cells Identified as Potential Driver of Alzheimer’s Disease Progression
In a significant advancement for neurobiology, researchers at Scripps Research have uncovered a specific molecular mechanism that triggers chronic brain…
Read More
CBD Shows Promise in Mitigating Neuroinflammation and Targeting Alzheimer’s Disease Progression
New clinical insights published in the journal eNeuro suggest that cannabidiol (CBD), a non-psychoactive compound derived from the cannabis plant,…
Read More
Sanofi’s Venglustat Receives Priority Review from US FDA for Type 3 Gaucher Disease
Sanofi has secured a significant milestone in its development of venglustat, an innovative oral glucosylceramide synthase inhibitor (GCSi), with the…
Read More
Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential
Traumatic brain injury (TBI) stands as a profound and pervasive global health crisis, impacting an estimated 69 million individuals each…
Read More
